Peter A Kouides MD

Clotting Disorder, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias

Medical and research director, Mary M. Gooley Hemophilia center, Clinical Professor of Medicine University of Rochester School of Medicine

Summary

Dr. Peter Kouides is a hematologist in Rochester, NY and is affiliated with Rochester General Hospital. He received his medical degree from State University of New York Upstate Medical University and has been in practice 32 years.

He specializes in benign hematology and is experienced in thrombotic disorders, bleeding disorders, hematological aspects/disorders of pregnancy general hematology, and Myeloproliferative disorders and MDS.

He is clinical professor of Medicine University of Rochester School of Medicine and adjunct faculty at Roswell Park Memorial Cancer Institute. He was an appointed member of the multi international 2021 Van Willebrand disease guidelines. His is past president of the Hemostasis and Thrombosis Research Society and past president of the Thrombosis and Hemostasis Societies of North America (THSNA). He has also served on the World Federation of Haemophilia twinning committee and has led two successive partnerships with his Rochester hemophilia treatment center and Bishkek, Kyrgyzstan then Kathmandu Nepal, four years each.

University of Rochester Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1993
Tufts Medical CenterResidency, Internal Medicine, 1986 - 1989
SUNY Upstate Medical UniversityClass of 1986

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification SoftLab, SCC Soft Computer, 2013-2017
CMS Meaningful Use Stage 1 Certification SoftLab, SCC Soft Computer, 2013-2017

PubMed

Vascular anatomic variant-related venous thromboembolism: what a hematologist needs to know.
Himal Kharel, Zeni Kharel, Damon E Houghton, Peter Kouides
Journal of Thrombosis and Haemostasis. 2026-07-01
Influenza as a Less Commonly Recognized Cause of Hemophagocytic Lymphohistiocytosis: A Systematic Review of Case Reports and Case Series.
Kavya Balusu, Ali Abdelhay, Fnu Payal, Peter Kouides
European Journal of Haematology. 2026-06-17
A multicenter analysis revisiting the PLASMIC score: performance limitations and the impact of age, MCV, and LDH.
Rishabh Singh, Ashley Khouri, Ho Jun Lee, Sanjana Kalvehalli Kashinath, Mukul Singal
Blood Vessels, Thrombosis & Hemostasis. 2026-05-01

Abstracts/Posters

Association of Obesity on Laboratory Profiles of Individuals with Type 1 Von Willebrand Disease and Low VWF in the Athn Dataset
Peter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study
Peter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Congenital FVIII/IX or VWF Deficiency Does Confer a Lower Rate of Myocardial Infarction-Related Mortality Despite Decreased Cardiovascular Interventions
Peter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018